Table 4. Means and frequencies of data reported in all sleep diaries.
Sublingual zolpidem 5 mg | Oral zolpidem 10 mg | |||||||
---|---|---|---|---|---|---|---|---|
Basal | Week 2 | Week 6 | Week 13 | Basal | Week 2 | Week 6 | Week 13 | |
Total diaries, n | 139 | 507 | 912 | 1,203 | 130 | 520 | 745 | 897 |
Weekends, n (%) | 48 (34) | 220 (43) | 395 (43) | 510 (42) | 42 (32) | 231 (44) | 324 (43) | 377 (42) |
Nights medication taken | - | 97 | 93 | 96 | - | 84 | 95 | 99 |
Rescue dose nights | - | 20 | 13 | 13 | - | 14 | 7 | 9 |
Perceived TST ≥ 6 hours | 33 | 65* | 69* | 68* | 23 | 53* | 49* | 54* |
SOL ≥ 30 minutes | 72 | 39 | 33* | 35* | 65 | 41 | 42* | 42* |
MOTN awakenings | 67* | 52† | 41* | 33* | 89* | 58† | 48* | 41* |
Sleep efficiency ≥ 85% | 37 | 64† | 71* | 69* | 44 | 57† | 59* | 57%† |
Data presented as %, unless otherwise specified.
The chi-square and z-test of column proportions were adjusted for all pairwise comparisons within a row using the Bonferroni correction. Proportions were compared between treatment groups at each phase of the protocol period.
MOTN awakenings = middle of the night awakening; SOL = sleep-onset latency; TST = total sleep time.
Statistically significant at p < 0.01.
Statistically significant at p < 0.05.